Published 3 days ago • loading... • Updated 2 days ago

Berger Montague and Reese Marketos Win $1.64 Billion False Claims Act Judgment

On Friday, March 31, 2025, Berger Montague and Reese Marketos obtained a $1.64 billion judgment in the District of New Jersey on behalf of two whistleblowers, Jessica Penelow and Christine Brancaccio, against Janssen Products, a Johnson & Johnson subsidiary, for its unlawful marketing scheme.
The judgment stemmed from a False Claims Act lawsuit filed in 2012 by former Janssen sales representatives Jessica Penelow and Christine Brancaccio, alleging that Janssen engaged in a deliberate and calculated scheme to unlawfully market the HIV medications Prezista and Intelence for off-label uses.
Following a six-week trial in 2024 led by Reese Marketos, the jury found that Janssen caused the submission of 159,574 false claims to the government for reimbursement related to the two drugs, after Berger Montague overcame numerous pretrial hurdles, including defeating Janssen's motion for summary judgment in 2021 and a motion to dismiss in 2017.
The jury initially awarded the U.S. Government $120 million in single damages on June 13, 2024, which was then trebled to $360 million under the False Claims Act, and further increased to $1.64 billion after penalties of $8,000 per false claim and post-judgment interest were added.
U.S. District Judge Zahid N. Quraishi stated that Janssen Products engaged in a deliberate and calculated scheme involving the unlawful marketing of Prezista and Intelence, and Sherrie Savett of Berger Montague, along with Pete Marketos of Reese Marketos, expressed their satisfaction with the court's decision, highlighting the significance of the ruling for Medicare, U.S. Taxpayers, and their clients.

Insights by Ground AI

Does this summary seem wrong?

18 Articles

All

Left

Center

Right

WREX

+15 Reposted by 15 other sources

Center

Berger Montague and Reese Marketos Win $1.64 Billion False Claims Act Judgment

PHILADELPHIA and DALLAS, March 31, 2025 /PRNewswire/ -- Berger Montague and Reese Marketos secured one of the largest False Claims Act recoveries in history for the U.S. government on Friday when the law firms obtained a $1.64 billion judgment on…

3 days ago

Read Full Article

Corporate Compliance Insights

Trump’s DOJ & the False Claims Act: What’s Next?

New AG’s history with qui tam cases offers clues about enforcement direction as technology transforms both compliance and investigations.

2 days ago

Read Full Article

News.law

Diopsys, Inc. Resolves DOJ Claims Over Nova ERG Marketing for $14.25 Million

Diopsys Inc., a medical device company based in Middletown, Pennsylvania, has agreed to pay up to $14.25 million to resolve allegations it violated the federal False Claims Act, the Justice Department announced March 28. The Justice Department said Diopsys knowingly submitted, or caused others to submit, false claims to Medicare and Medicaid involving the use of its NOVA device for vision testing procedures. Read more at Newsbreak.

2 days ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year